z-logo
open-access-imgOpen Access
Low Levels of Neutralizing Antibodies After Natural Infection With Severe Acute Respiratory Syndrome Coronavirus 2 in a Community-Based Serological Study
Author(s) -
Thomas W. McDade,
Amelia Sancilio,
Richard T. D’Aquila,
Brian Mustanski,
Lauren A. Vaught,
Nina L. Reiser,
Matthew E Velez,
Ryan R. Hsieh,
Daniel T. Ryan,
Rana Saber,
Elizabeth M. McNally,
Alexis R. Demonbreun
Publication year - 2022
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofac055
Subject(s) - medicine , serology , virology , antibody , coronavirus , covid-19 , respiratory system , immunology , natural history , disease , infectious disease (medical specialty)
Background Confidence in natural immunity after infection with severe acute respiratory syndrome coronavirus 2 is one reason for vaccine hesitancy. Methods We measured antibody-mediated neutralization of spike protein-ACE2 receptor binding in a large community-based sample of seropositive individuals who differed in severity of infection (N = 790). Results A total of 39.8% of infections were asymptomatic, 46.5% were symptomatic with no clinical care, 13.8% were symptomatic with clinical care, and 3.7% required hospitalization. Moderate/high neutralizing activity was present after 41.3% of clinically managed infections, in comparison with 7.9% of symptomatic and 1.9% of asymptomatic infections. Conclusions Prior coronavirus disease 2019 infection does not guarantee a high level of antibody-mediated protection against reinfection in the general population.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom